Annual Cash & Cash Equivalents
$375.94 M
-$754.00 K-0.20%
December 31, 2023
Summary
- As of February 7, 2025, BBIO annual cash & cash equivalents is $375.94 million, with the most recent change of -$754.00 thousand (-0.20%) on December 31, 2023.
- During the last 3 years, BBIO annual cash & cash equivalents has risen by +$19.85 million (+5.58%).
- BBIO annual cash & cash equivalents is now -13.79% below its all-time high of $436.09 million, reached on December 31, 2018.
Performance
BBIO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$266.32 M
-$141.63 M-34.72%
September 30, 2024
Summary
- As of February 7, 2025, BBIO quarterly cash and cash equivalents is $266.32 million, with the most recent change of -$141.63 million (-34.72%) on September 30, 2024.
- Over the past year, BBIO quarterly cash and cash equivalents has dropped by -$109.61 million (-29.16%).
- BBIO quarterly cash and cash equivalents is now -64.82% below its all-time high of $757.05 million, reached on March 31, 2020.
Performance
BBIO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BBIO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.2% | -29.2% |
| 3 y3 years | +5.6% | -29.2% |
| 5 y5 years | -13.8% | -29.2% |
BBIO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.5% | at low | -47.3% | at low |
| 5 y | 5-year | -4.5% | +5.6% | -64.8% | +47.7% |
| alltime | all time | -13.8% | +308.6% | -64.8% | +47.7% |
BridgeBio Pharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $266.32 M(-34.7%) |
| Jun 2024 | - | $407.96 M(-14.2%) |
| Mar 2024 | - | $475.22 M(+26.4%) |
| Dec 2023 | $375.94 M(-0.2%) | $375.94 M(-25.6%) |
| Sep 2023 | - | $505.21 M(+67.0%) |
| Jun 2023 | - | $302.44 M(-25.8%) |
| Mar 2023 | - | $407.37 M(+8.1%) |
| Dec 2022 | $376.69 M(-4.3%) | $376.69 M(-22.0%) |
| Sep 2022 | - | $483.24 M(+2.8%) |
| Jun 2022 | - | $470.10 M(+26.5%) |
| Mar 2022 | - | $371.55 M(-5.6%) |
| Dec 2021 | $393.77 M | $393.77 M(+118.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $180.35 M(-52.3%) |
| Jun 2021 | - | $378.42 M(-19.7%) |
| Mar 2021 | - | $471.18 M(+32.3%) |
| Dec 2020 | $356.08 M(-2.1%) | $356.08 M(-3.0%) |
| Sep 2020 | - | $366.97 M(-32.2%) |
| Jun 2020 | - | $540.92 M(-28.5%) |
| Mar 2020 | - | $757.05 M(+108.1%) |
| Dec 2019 | $363.77 M(-16.6%) | $363.77 M(-12.1%) |
| Sep 2019 | - | $413.97 M(+40.9%) |
| Jun 2019 | - | $293.80 M(-21.2%) |
| Mar 2019 | - | $373.03 M(-14.5%) |
| Dec 2018 | $436.09 M(+374.0%) | $436.09 M |
| Dec 2017 | $92.00 M | - |
FAQ
- What is BridgeBio Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BridgeBio Pharma?
- What is BridgeBio Pharma annual cash & cash equivalents year-on-year change?
- What is BridgeBio Pharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly cash and cash equivalents year-on-year change?
What is BridgeBio Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of BBIO is $375.94 M
What is the all time high annual cash & cash equivalents for BridgeBio Pharma?
BridgeBio Pharma all-time high annual cash & cash equivalents is $436.09 M
What is BridgeBio Pharma annual cash & cash equivalents year-on-year change?
Over the past year, BBIO annual cash & cash equivalents has changed by -$754.00 K (-0.20%)
What is BridgeBio Pharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BBIO is $266.32 M
What is the all time high quarterly cash and cash equivalents for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly cash and cash equivalents is $757.05 M
What is BridgeBio Pharma quarterly cash and cash equivalents year-on-year change?
Over the past year, BBIO quarterly cash and cash equivalents has changed by -$109.61 M (-29.16%)